MARCHF1 and neoplasm: The decrease in lysosomal degradation of MHC-II in M-MDSCs by targeting the membrane-associated RING-CH1 (MARCH1) E3 ubiquitin ligase indirectly attenuates the suppressive function of M-MDSCs, resulting in markedly decreased tumor volume and a robust anti-tumor immunity [77].